{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T13:13:57Z","timestamp":1792588437065,"version":"4.5.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.autrev.2026.104078","type":"journal-article","created":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T06:57:48Z","timestamp":1779346668000},"page":"104078","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Hydroxychloroquine and teratogenic risk in pregnancy in systemic autoimmune diseases: A systematic narrative review"],"prefix":"10.1016","volume":"25","author":[{"given":"Enrique","family":"Esteve-Valverde","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesc","family":"Miro-Mur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariadna","family":"Anunciacion-LLunell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Ockova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruna A.","family":"Gon\u00e7alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Ferrer-Oliveras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Morales-Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariela","family":"Hoxha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricard","family":"Cervera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaume","family":"Alijotas-Reig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.autrev.2026.104078_bb0005","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1136\/ard-2023-224762","article-title":"EULAR recommendations for the management of systemic lupus erythematosus: 2023 update","volume":"83","author":"Fanouriakis","year":"2024","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.autrev.2026.104078_bb0010","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1136\/annrheumdis-2019-216114","article-title":"EULAR recommendations for the management of Sj\u00f6gren\u2019s syndrome with topical and systemic therapies","volume":"79","author":"Ramos-Casals","year":"2020","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.autrev.2026.104078_bb0015","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2024-001239","article-title":"Effect of hydroxychloroquine on pregnancy outcome in patients with SLE: a systematic review and meta-analysis","volume":"11","author":"Zhu","year":"2024","journal-title":"Lupus Sci Med."},{"issue":"3","key":"10.1016\/j.autrev.2026.104078_bb0020","doi-asserted-by":"crossref","first-page":"675","DOI":"10.3390\/jcm11030675","article-title":"Pathogenesis, diagnosis and management of obstetric antiphospholipid syndrome: a comprehensive review","volume":"11","author":"Alijotas-Reig","year":"2022","journal-title":"J Clin Med"},{"issue":"7","key":"10.1016\/j.autrev.2026.104078_bb0025","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1177\/09612033211007199","article-title":"Hydroxychloroquine prophylaxis for preeclampsia, hypertension and prematurity in pregnant patients with systemic lupus erythematosus: a meta-analysis","volume":"30","author":"Duan","year":"2021","journal-title":"Lupus"},{"issue":"2","key":"10.1016\/j.autrev.2026.104078_bb0030","article-title":"Immunomodulatory effects of hydroxychloroquine in autoimmune diseases","volume":"16","author":"Wang","year":"2025","journal-title":"World J Clin Immunol"},{"issue":"1","key":"10.1016\/j.autrev.2026.104078_bb0035","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/eji.202149361","article-title":"Hydroxychloroquine inhibits proteolytic processing of endogenous TLR7 protein in human primary plasmacytoid dendritic cells","volume":"52","author":"Cenac","year":"2022","journal-title":"Eur J Immunol"},{"issue":"8","key":"10.1016\/j.autrev.2026.104078_bb0040","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1080\/15548627.2018.1474314","article-title":"Chloroquine inhibits autophagic flux by decreasing autophagosome-lysosome fusion","volume":"14","author":"Mauthe","year":"2018","journal-title":"Autophagy"},{"issue":"6","key":"10.1016\/j.autrev.2026.104078_bb0045","doi-asserted-by":"crossref","first-page":"847","DOI":"10.3899\/jrheum.200726","article-title":"Hydroxychloroquine suppresses interferon-inducible genes and B cell activating factor in patients with incomplete and new-onset systemic lupus erythematosus","volume":"48","author":"Lambers","year":"2021","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2026.104078_bb0050","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ijcard.2021.04.062","article-title":"Hydroxychloroquine reduces interleukin-6 levels after myocardial infarction: the randomized, double-blind, placebo-controlled OXI pilot trial","volume":"337","author":"Ulander","year":"2021","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.autrev.2026.104078_bb0055","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.intimp.2018.08.008","article-title":"Attenuation of antimalarial agent hydroxychloroquine on TNF-\u03b1-induced endothelial inflammation","volume":"63","author":"Li","year":"2018","journal-title":"Int Immunopharmacol"},{"issue":"3","key":"10.1016\/j.autrev.2026.104078_bb0060","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1093\/cei\/uxad005","article-title":"Chloroquine reduces neutrophil extracellular trap (NET) formation through inhibition of peptidyl arginine deiminase 4 (PAD4)","volume":"211","author":"Ivey","year":"2023","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"10.1016\/j.autrev.2026.104078_bb0065","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2021-000475","article-title":"Hydroxychloroquine is associated with lower platelet activity and improved vascular health in systemic lupus erythematosus","volume":"8","author":"Cornwell","year":"2021","journal-title":"Lupus Sci Med"},{"key":"10.1016\/j.autrev.2026.104078_bb0070","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jaut.2016.04.008","article-title":"Complement inhibition by hydroxychloroquine prevents placental and fetal brain abnormalities in antiphospholipid syndrome","volume":"75","author":"Bertolaccini","year":"2016","journal-title":"J Autoimmun"},{"issue":"15","key":"10.1016\/j.autrev.2026.104078_bb0075","doi-asserted-by":"crossref","first-page":"4357","DOI":"10.1111\/jcmm.17459","article-title":"Protection by hydroxychloroquine prevents placental injury in obstetric antiphospholipid syndrome","volume":"26","author":"Liu","year":"2022","journal-title":"J Cell Mol Med"},{"issue":"3","key":"10.1016\/j.autrev.2026.104078_bb0080","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/s41419-018-0378-3","article-title":"Hydroxychloroquine attenuates renal ischemia\/reperfusion injury by inhibiting cathepsin-mediated NLRP3 inflammasome activation","volume":"9","author":"Tang","year":"2018","journal-title":"Cell Death Dis"},{"issue":"4","key":"10.1016\/j.autrev.2026.104078_bb0085","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.autrev.2014.12.006","article-title":"Hydroxychloroquine as an anti-thrombotic in antiphospholipid syndrome","volume":"14","author":"Belizna","year":"2015","journal-title":"Autoimmun Rev"},{"issue":"6","key":"10.1016\/j.autrev.2026.104078_bb0090","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1111\/jth.12570","article-title":"Hydroxychloroquine restores trophoblast fusion affected by antiphospholipid antibodies","volume":"12","author":"Marchetti","year":"2014","journal-title":"J Thromb Haemost"},{"issue":"7","key":"10.1016\/j.autrev.2026.104078_bb0095","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.autrev.2017.05.006","article-title":"Refractory obstetrical antiphospholipid syndrome: Features, treatment and outcome in a European multicenter retrospective study","volume":"16","author":"Mekinian","year":"2017","journal-title":"Autoimmun Rev"},{"issue":"11","key":"10.1016\/j.autrev.2026.104078_bb0100","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1182\/blood-2009-04-213520","article-title":"Hydroxychloroquine protects the annexin A5 anticoagulant shield from disruption by antiphospholipid antibodies: evidence for a novel effect for an old antimalarial drug","volume":"115","author":"Rand","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2026.104078_bb0105","series-title":"Textbook of rheumatology","first-page":"731","article-title":"Antimalarial drugs","author":"Rynes","year":"1993"},{"issue":"10","key":"10.1016\/j.autrev.2026.104078_bb0110","first-page":"1843","article-title":"Studies on the mechanism of inhibition of chemotactic factor-stimulated neutrophil superoxide release by chloroquine and hydroxychloroquine","volume":"36","author":"Hurst","year":"1987","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.autrev.2026.104078_bb0115","article-title":"Chloroquine reduces neutrophil extracellular trap (NET) formation","volume":"14","author":"Ivey","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2026.104078_bb0120","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.627639","article-title":"Overcoming chemoresistance: altering pH of cellular compartments by chloroquine and hydroxychloroquine","volume":"9","author":"Halcrow","year":"2021","journal-title":"Front Cell Dev Biol"},{"issue":"7","key":"10.1016\/j.autrev.2026.104078_bb0125","first-page":"401","article-title":"A pharmacokinetics-informed approach to navigating hydroxychloroquine use: Implications for toxicity and efficacy","volume":"2","author":"Scheetz","year":"2020","journal-title":"ACR Open Rheumatol"},{"issue":"5","key":"10.1016\/j.autrev.2026.104078_bb0130","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.ajog.2020.12.1218","article-title":"Hydroxychloroquine early in pregnancy and risk of birth defects: don\u2019t throw out the baby with the bathwater","volume":"224","author":"Bermas","year":"2021","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.autrev.2026.104078_bb0135","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1191\/096120301678646137","article-title":"Hydroxychloroquine (HCQ) in lupus pregnancy: double-blind and placebo-controlled study","volume":"10","author":"Levy","year":"2001","journal-title":"Lupus"},{"issue":"11","key":"10.1016\/j.autrev.2026.104078_bb0140","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1002\/art.11304","article-title":"Safety of hydroxychloroquine in pregnant patients with connective tissue diseases: a study of 133 cases compared with a control group","volume":"48","author":"Costedoat-Chalumeau","year":"2003","journal-title":"Arthritis Rheum"},{"issue":"11","key":"10.1016\/j.autrev.2026.104078_bb0145","doi-asserted-by":"crossref","first-page":"3640","DOI":"10.1002\/art.22159","article-title":"Hydroxychloroquine in lupus pregnancy","volume":"54","author":"Clowse","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2026.104078_bb0150","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.reprotox.2013.04.005","article-title":"Pregnancy outcome following in utero exposure to hydroxychloroquine: a prospective comparative observational study","volume":"39","author":"Diav-Citrin","year":"2013","journal-title":"Reprod Toxicol"},{"issue":"2","key":"10.1016\/j.autrev.2026.104078_bb0155","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/art.38262","article-title":"Risk of adverse fetal outcomes associated with immunosuppressive medications for chronic immune-mediated diseases in pregnancy","volume":"66","author":"Cooper","year":"2014","journal-title":"Arthritis Rheumatol"},{"issue":"5","key":"10.1016\/j.autrev.2026.104078_bb0160","doi-asserted-by":"crossref","first-page":"377","DOI":"10.3109\/03009742.2015.1013982","article-title":"Maternal and foetal outcomes in pregnant systemic lupus erythematosus patients: an incident cohort from a stable referral population followed during 1990-2010","volume":"44","author":"Jakobsen","year":"2015","journal-title":"Scand J Rheumatol"},{"issue":"10","key":"10.1016\/j.autrev.2026.104078_bb0165","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.120.008686","article-title":"Electrocardiographic QT intervals in infants exposed to hydroxychloroquine throughout gestation","volume":"13","author":"Friedman","year":"2020","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"3","key":"10.1016\/j.autrev.2026.104078_bb0170","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.jacc.2020.05.045","article-title":"Hydroxychloroquine to prevent recurrent congenital heart block in fetuses of anti-SSA\/Ro-positive mothers","volume":"76","author":"Izmirly","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.autrev.2026.104078_bb0175","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.722511","article-title":"Chloroquine and hydroxychloroquine use during pregnancy and the risk of adverse pregnancy outcomes using real-world evidence","volume":"12","author":"B\u00e9rard","year":"2021","journal-title":"Front Pharmacol"},{"issue":"5","key":"10.1016\/j.autrev.2026.104078_bb0180","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1093\/rheumatology\/keaa592","article-title":"Fetal safety of chloroquine and hydroxychloroquine use during pregnancy: a nationwide cohort study","volume":"60","author":"Andersson","year":"2021","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"10.1016\/j.autrev.2026.104078_bb0185","first-page":"482","article-title":"Hydroxychloroquine in pregnancy and risk of congenital malformations: a prospective controlled cohort study from the OTIS Autoimmune Diseases in Pregnancy Project","volume":"80","author":"Smeeth","year":"2021","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.autrev.2026.104078_bb0190","doi-asserted-by":"crossref","first-page":"290.e1","DOI":"10.1016\/j.ajog.2020.09.007","article-title":"Hydroxychloroquine early in pregnancy and risk of birth defects: a population-based cohort study","volume":"224","author":"Huybrechts","year":"2021","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.autrev.2026.104078_bb0195","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1093\/rheumatology\/keac372","article-title":"Outcomes of children born to mothers with systemic lupus erythematosus exposed to hydroxychloroquine or azathioprine","volume":"62","author":"Reynolds","year":"2023","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.autrev.2026.104078_bb0200","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1093\/rheumatology\/keae168","article-title":"Hydroxychloroquine in lupus or rheumatoid arthritis pregnancy and risk of major congenital malformations: a population-based cohort study","volume":"64","author":"Nguyen","year":"2025","journal-title":"Rheumatology (Oxford)"},{"issue":"10","key":"10.1016\/j.autrev.2026.104078_bb0205","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1177\/09612033221107538","article-title":"Improved pregnancy outcomes in systemic lupus erythematosus: a retrospective study of pregnancies from a single Centre in Denmark from 2010-2020 compared with the period 1990-2010","volume":"31","author":"Gohr","year":"2022","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2026.104078_bb0210","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1002\/bdr2.1943","article-title":"Maternal exposure to hydroxychloroquine and major birth defects","volume":"113","author":"Howley","year":"2021","journal-title":"Birth Defects Res"},{"issue":"7","key":"10.1016\/j.autrev.2026.104078_bb0215","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1136\/ard.55.7.486","article-title":"Hydroxychloroquine and lupus pregnancy: review of a series of 36 cases","volume":"55","author":"Buchanan","year":"1996","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"10.1016\/j.autrev.2026.104078_bb0220","doi-asserted-by":"crossref","first-page":"e501","DOI":"10.1016\/S2665-9913(23)00215-1","article-title":"Global comment on the use of hydroxychloroquine during the periconception period and pregnancy in women with autoimmune diseases","volume":"5","author":"Schreiber","year":"2023","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.autrev.2026.104078_bb0225","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.3899\/jrheum.140583","article-title":"Disease severity and pregnancy outcomes in women with rheumatoid arthritis: results from the Organization of Teratology Information Specialists Autoimmune Diseases in pregnancy project","volume":"42","author":"Bharti","year":"2015","journal-title":"J Rheumatol"},{"issue":"1","key":"10.1016\/j.autrev.2026.104078_bb0230","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/j.1749-6632.2010.05938.x","article-title":"Inflammation and pregnancy: the role of the immune system at the implantation site","volume":"1221","author":"Mor","year":"2011","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"10.1016\/j.autrev.2026.104078_bb0235","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.autrev.2014.08.040","article-title":"Obstetrical APS: is there a place for hydroxychloroquine to improve the pregnancy outcome?","volume":"14","author":"Mekinian","year":"2015","journal-title":"Autoimmun Rev"},{"issue":"2","key":"10.1016\/j.autrev.2026.104078_bb0240","doi-asserted-by":"crossref","first-page":"113","DOI":"10.47102\/annals-acadmedsg.2023262","article-title":"Mechanisms and roles of hydroxychloroquine in pregnancy in rheumatic diseases","volume":"54","author":"Kong","year":"2025","journal-title":"Ann Acad Med Singapore"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997226000923?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997226000923?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T07:30:37Z","timestamp":1790494237000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997226000923"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":48,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S1568997226000923"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2026.104078","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hydroxychloroquine and teratogenic risk in pregnancy in systemic autoimmune diseases: A systematic narrative review","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2026.104078","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104078"}}